Skip to content

IMVT

Immunovant, Inc.

NASDAQ · USHealthcareBiotechnology
$40.16-0.24%

Price as of Jul 20, 2026

IMVT ownership

Immunovant, Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
28
Net (3m)
-$12.5M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +33%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 10, 2026Van Tuyl Christopherofficer: Chief Legal OfficerSell63$39.99
Jul 10, 2026Stout Jay Sofficer: Chief Technology OfficerSell105$39.99
Jul 10, 2026Gloria Melanieofficer: Chief Operating OfficerSell1,930$39.53
Jul 10, 2026Stout Jay Sofficer: Chief Technology OfficerSell1,906$39.53
Jul 10, 2026Van Tuyl Christopherofficer: Chief Legal OfficerSell1,143$39.53
Jul 10, 2026Stout Jay Sofficer: Chief Technology OfficerSell77$39.99
Jul 10, 2026Stout Jay Sofficer: Chief Technology OfficerSell1,399$39.53
Jul 10, 2026Gloria Melanieofficer: Chief Operating OfficerSell106$39.99
Jul 6, 2026Venker Ericdirector, officer: Chief Executive OfficerOption92,188$14.46
Jul 6, 2026Venker Ericdirector, officer: Chief Executive OfficerSell3,092$38.48
Jun 26, 2026Gloria Melanieofficer: Chief Operating OfficerSell14,748$38.18
Jun 26, 2026Stout Jay Sofficer: Chief Technology OfficerSell6,723$38.94
Jun 26, 2026Pande AtuldirectorSell1,500$38.01
Jun 26, 2026Girao Tiagoofficer: Chief Financial OfficerOption10,000$15.90
Jun 26, 2026Pande AtuldirectorOption1,500$8.43
Jun 26, 2026Van Tuyl Christopherofficer: Chief Legal OfficerSell2,842$38.96
Jun 26, 2026Gloria Melanieofficer: Chief Operating OfficerSell2,966$38.95
Jun 26, 2026Stout Jay Sofficer: Chief Technology OfficerSell33,277$38.18
Jun 26, 2026Van Tuyl Christopherofficer: Chief Legal OfficerSell14,982$38.19
Jun 26, 2026Van Tuyl Christopherofficer: Chief Legal OfficerOption17,824$15.20
Jun 26, 2026Girao Tiagoofficer: Chief Financial OfficerSell10,000$38.46
Jun 22, 2026Van Tuyl Christopherofficer: Chief Legal OfficerSell2,634$35.39
Jun 16, 2026Pande AtuldirectorOption1,500$8.43
Jun 16, 2026Pande AtuldirectorSell1,500$34.02
May 29, 2026Fromkin Andrew J.directorSell11,483$32.64
May 29, 2026Fromkin Andrew J.directorOption31,668$4.99
May 29, 2026Fromkin Andrew J.directorOption77,181$8.43
May 29, 2026Fromkin Andrew J.directorOption16,260$14.70
May 29, 2026Fromkin Andrew J.directorOption71,492$7.94
May 29, 2026Fromkin Andrew J.directorSell210,468$33.56

Source: IMVT SEC Form 4 filings, latest Jul 10, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their IMVT positions over the last 6 months (SEC Form 13F).

Increased
166
New positions
80
Reduced
106
Sold out
53
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased17.0MFeb 17, 2026
FMR LLCReduced16.9MMay 15, 2026
DEEP TRACK CAPITAL, LPIncreased11.5MFeb 13, 2026
DEEP TRACK CAPITAL, LPUnchanged11.5MMay 15, 2026
VANGUARD GROUP INCIncreased7.8MJan 29, 2026
BLACKROCK, INC.Increased6.6MMay 13, 2026
BLACKROCK, INC.Increased6.1MFeb 12, 2026
ARMISTICE CAPITAL, LLCReduced5.7MFeb 17, 2026
ARMISTICE CAPITAL, LLCReduced5.5MMay 15, 2026
BAKER BROS. ADVISORS LPUnchanged5.5MMay 15, 2026
BAKER BROS. ADVISORS LPUnchanged5.5MFeb 17, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Reduced5.1MFeb 19, 2026
MORGAN STANLEYIncreased4.8MFeb 13, 2026
STATE STREET CORPIncreased4.5MMay 15, 2026
TCG CROSSOVER MANAGEMENT, LLCIncreased4.5MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.